{"disease":{"id":"human-papillomavirus-hpv","name":"human papillomavirus hpv"},"drugs":{"marketed":[{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (immunocompromised)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (pregnancy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (adolescent)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (adult)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (immunocompromised)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (pregnancy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (adolescent)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07200414","title":"Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)","phase":"NA","overall_status":"COMPLETED","enrollment_count":12654,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT06815939","title":"Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"DL Analytics","has_results":false},{"nct_id":"NCT01062074","title":"GARDASIL Reexamination Study (V501-059)","phase":"","overall_status":"COMPLETED","enrollment_count":3605,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03429413","title":"Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1296,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT04333212","title":"HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix","phase":"NA","overall_status":"COMPLETED","enrollment_count":1103,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT03111251","title":"Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics","phase":"NA","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT07275333","title":"Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT02524223","title":"Prevalence of HPV Transmission During Medically Assisted Procreation Procedures","phase":"NA","overall_status":"COMPLETED","enrollment_count":915,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT00481767","title":"Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":676,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05587738","title":"Human Papillomavirus in Young People Epidemiological Research 4","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Monash University","has_results":false},{"nct_id":"NCT03000998","title":"Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake","phase":"NA","overall_status":"COMPLETED","enrollment_count":432,"lead_sponsor_name":"Klein Buendel, Inc.","has_results":false},{"nct_id":"NCT07209917","title":"Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India","phase":"NA","overall_status":"RECRUITING","enrollment_count":420,"lead_sponsor_name":"University of California, Irvine","has_results":false},{"nct_id":"NCT06800456","title":"The Role of Cyberchondria Severity in the Relationship Between HPV Awareness and Vaccination Attitudes in Adult Women","phase":"","overall_status":"COMPLETED","enrollment_count":337,"lead_sponsor_name":"Acibadem University","has_results":false},{"nct_id":"NCT05539638","title":"The Role of Circulating Tumour DNA in Head and Neck Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT05587725","title":"Human Papillomavirus in Young People Epidemiological Research 3","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Monash University","has_results":false},{"nct_id":"NCT07420556","title":"Effect of Different HPV Education Methods on Vaccination Intention in Young Women","phase":"NA","overall_status":"RECRUITING","enrollment_count":117,"lead_sponsor_name":"Emel GÜÇLÜ CİHAN","has_results":false},{"nct_id":"NCT07231263","title":"Effect of HPV Education on Women's Knowledge","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Kahramanmaras Sutcu Imam University","has_results":false},{"nct_id":"NCT07248904","title":"The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Health Beliefs, and Vaccination Behavior Intentions","phase":"NA","overall_status":"RECRUITING","enrollment_count":88,"lead_sponsor_name":"Cukurova University","has_results":false},{"nct_id":"NCT07303751","title":"Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Institut d'Investigació Biomèdica de Bellvitge","has_results":false},{"nct_id":"NCT06705322","title":"Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix.","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":79,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07209189","title":"Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT07320157","title":"The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake","phase":"NA","overall_status":"RECRUITING","enrollment_count":64,"lead_sponsor_name":"Ufuk University","has_results":false},{"nct_id":"NCT04708470","title":"A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":55,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03799445","title":"Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":37,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT03180684","title":"Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":true},{"nct_id":"NCT06997094","title":"Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03618134","title":"Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":19,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT06544720","title":"SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"The Affiliated Hospital of Qingdao University","has_results":false},{"nct_id":"NCT04541355","title":"Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Hyunseok Kang, MD","has_results":true},{"nct_id":"NCT02308241","title":"Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT03912831","title":"Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03197025","title":"Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05472220","title":"Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Pamela Munster","has_results":false},{"nct_id":"NCT04849377","title":"RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Icahn School of Medicine at Mount Sinai","has_results":false}],"total":34},"guidelines":[],"source":"Drug Landscape verified database"}